Both treatments increase patient self-efficacy; improvements from baseline to 12-month follow-up for both treatments in all primary outcomes<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, June 6, 2022 (HealthDay News) — For adults with migraine, migraine-specific, integrative cognitive behavioral therapy (miCBT) and relaxation training (RLX) are both beneficial, with no significant between-group difference seen at follow-up, according to a study published online April 28 in Frontiers in Neurology<\/em>.<\/p>\n Timo Klan, Ph.D., from the Johannes Gutenberg University of Mainz in Germany, and colleagues conducted a three-armed, open-label trial involving 121 adults with migraine who were assigned to miCBT combining several approaches (trigger and stress management, coping with fear of attacks, relaxation training), a single behavioral approach (RLX) as an active control group, and a waiting-list control group (WLC). miCBT and RLX consisted of seven 90 minute sessions. Participants who completed WLC were then randomly assigned to the treatment groups.<\/p>\n The researchers found that significantly stronger pre-post improvement in self-efficacy was seen in both treatment groups compared with WLC in mixed-model analyses of the intention-to-treat sample; there were no other significant between-group differences. In follow-up analyses, significant within-group improvements were seen from baseline to 12-month follow-up for both treatments in all four primary outcomes (headache days, headache-related disability, emotional distress, and self-efficacy). At follow-up, between-group effects (miCBT versus RLX) were not significant.<\/p>\n “In the follow-up, both interventions yielded significant within-group improvements in most of the outcomes,” the authors write. “However, and contrary to expectations, miCBT was not superior to RLX in improving clinical outcomes, neither in the pre-post analyses nor in the follow-up analyses.”<\/p>\n